nervous system interfaces that leverage structural, computational, and mathematical modeling to develop devices that decode neural activity (identify how it corresponds to a particular behavior or cognitive state, such as sensorimotor function, memory, or neuropsychiatric function) and use this information to deliver targeted interventions or therapies to facilitate performance. (3) Performance enhancement, namely technologies that augment human physiology at the cellular, molecular, and physiological levels giving the end user novel or enhanced physical and psychological capabilities. (4) Gene editing, including tools that facilitate deoxyribonucleic acid (DNA) sequence deletion, replacement, or insertion into cellular or organismal genetic material, thereby modulating genetic function for applications that include treating and preventing disease, and improving function of biological systems. (5) Biomolecular sequencing and synthesis, namely the processes by which biomolecular components (such as deoxyribonucleic acid and ribonucleic acid) can be measured (sequencing) or generated (synthesis) for uses in engineering biology, biomanufacturing, and other medical and nonmedical applications. 232. Cyber science and technology activities roadmap and reports (a) Roadmap for science and technology activities to support development of cyber capabilities (1) Roadmap required The Secretary of Defense, acting through the Under Secretary of Defense for Research and Engineering, shall develop a roadmap for science and technology activities of the Department of Defense to support development of cyber capabilities to meet Department needs and missions. (2) Goal of consistency The Secretary shall develop the roadmap required by paragraph (1) to ensure consistency with appropriate Federal interagency, industry, and academic activities. (3) Scope The roadmap required by paragraph (1) shall— (A) cover the development of capabilities that will likely see operational use within the next 25 years or earlier